<DOC>
	<DOC>NCT02232061</DOC>
	<brief_summary>This study will evaluate if patients who had a serious cardiovascular event upon initiation of fingolimod are at risk to delevop long term other cardiovascular events</brief_summary>
	<brief_title>Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks in Patients Treated With Fingolimod</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<criteria>Patients participating in study FTY720D2406 who experienced a serious cardiovascular event during their fingolimod treatment initiation Patients still on fingolimod after the this first dose serious event</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>multiple sclerosis, fingolimod,</keyword>
</DOC>